Table 1 Fatty Acid Composition of HUVECs treated by 9t18:1 and 11t18:1(mg/g total fat).
Fatty acids in lipid fractions | control | leptin | 11t18:1(100 μmol/L) + Leptin (75 nmol/L) | 11t18:1/(μmol/L) | 9t18:1/(μmol/L) | ||||
|---|---|---|---|---|---|---|---|---|---|
25 | 50 | 100 | 25 | 50 | 100 | ||||
SFA | 289.44 ± 3.28ab | 49.68 ± 0.96a | 200.56 ± 2.72c | 280.08 ± 4.16ab | 268.48 ± 6.40b | 205.44 ± 1.76c | 290.00 ± 14.24a | 246.72 ± 16.08b | 173.60 ± 10.08d |
ΣcisMUFA | 406.32 ± 3.12a | 416.08 ± 1.44a | 302.96 ± 2.40c | 351.44 ± 2.72b | 305.68 ± 8.80c | 292.72 ± 3.36d | 360.56 ± 6.56b | 349.76 ± 9.68b | 339.76 ± 14.08b |
ΣPUFA | 91.28 ± 2.88a | 86.48 ± 0.56a | 29.20 ± 0.96c | 72.56 ± 2.48ab | 64.88 ± 11.84b | 62.64 ± 0.96b | 61.36 ± 7.36b | 56.72 ± 4.48b | 47.20 ± 4.16bc |
ΣTFA | 12.96 ± 0.16e | 7.76 ± 0.80e | 267.28 ± 1.60a | 95.92 ± 2.40d | 160.96 ± 1.36c | 239.20 ± 0.48b | 88.08 ± 3.04d | 146.80 ± 3.68c | 239.44 ± 11.28b |
ΣCLA | 1.36 ± 0.08d | 0.96 ± 0.40d | 39.52 ± 1.04bc | 26.16 ± 2.08c | 40.48 ± 0.24b | 79.52 ± 1.04a | 1.68 ± 0.48d | 1.12 ± 0.72d | 2.64 ± 1.20d |
9t18:1 | 3.68 ± 0.80d | 4.00 ± 0.16d | 3.92 ± 0.08d | 3.76 ± 0.80d | 3.92 ± 0.80 d | 2.40 ± 1.04d | 80.48 ± 7.04c | 137.68 ± 12.24b | 270.88 ± 9.68a |
11t18:1 | 1.92 ± 0.08e | 2.88 ± 0.80e | 277.12 ± 0.32a | 73.36 ± 5.68d | 120.16 ± 2.48c | 241.52 ± 0.24b | 1.52 ± 0.80e | 0.64 ± 0.16e | 1.04 ± 0.56e |
9c11t-CLA | 0.56 ± 0.00d | ND | 36.32 ± 0.80b | 23.28 ± 2.16c | 35.44 ± 0.80b | 70.08 ± 1.84a | 0.56 ± 0.80d | 1.12 ± 0.64d | 0.56 ± 0.96d |